ADHD Trial, Recruiting NCT07459699 Sponsor: Probi AB Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT07459699
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children aged 8 to 11 years old, either male or female
  • Children who have mild ADHD symptoms
  • Children whose parents or legal guardians are willing and able to follow the study procedures and take part in the research alongside the child

Who may not be able to join:

  • Children who have a metabolic disorder
  • Children who have a severe long-term illness
  • Children who have gut or digestive conditions that the trial investigator determines would interfere with the study
  • Children who have a neurological condition affecting brain function, such as intellectual disability, autism spectrum disorder, epilepsy, or narcolepsy
  • Children who are currently taking medication that primarily affects the brain and central nervous system, or who have a major psychiatric condition that has required hospitalisation
  • Children who have a known or suspected food allergy, food intolerance, or sensitivity to any ingredient in the study products
  • Children who have taken prebiotic or probiotic supplements in the month before joining, or who have taken antibiotics for more than one week in the three months before joining
  • Children who are currently taking part in another clinical trial, or who are within a waiting period following a previous clinical trial
  • Children whose parents or legal guardians have a psychological or language-related difficulty that would prevent them from signing the consent form
  • Children whose parents or legal guardians cannot be reached in an emergency

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-021-25077027

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Probi AB
Registry
ClinicalTrials.gov
Start date
25 May 2026
Est. completion
1 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Conner's Continuous Performance test-3 (CPT-3) hit reaction time (HRT) block change score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov